AGEs/RAGE blockade downregulates Endothenin-1 (ET-1), mitigating Human Umbilical Vein Endothelial Cells (HUVEC) injury in deep vein thrombosis (DVT)

References

• Badireddy M, Mudipalli VR. Deep venous thrombosis prophylaxis. Treasure Island (FL): StatPearls; 2020.
   Google Scholar
• Thachil J. Deep vein thrombosis. Hematology. 2014;19(5):309–310.
   PubMed Web of Science ®Google Scholar
• Li J, Zhu Y, Chen W, et al. Incidence and locations of deep venous thrombosis of the lower extremity following surgeries of tibial plateau fractures: a prospective cohort study. J Orthop Surg Res. 2020b;15(1):605.
   PubMed Web of Science ®Google Scholar
• Saleh J, El-Othmani MM, Saleh KJ. Deep vein thrombosis and pulmonary embolism considerations in orthopedic surgery. Orthop Clin North Am. 2017;48(2):127–135.
   PubMed Web of Science ®Google Scholar
• Di Nisio M, Van Es N, Buller HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016;388(10063):3060–3073.
   PubMed Web of Science ®Google Scholar
• Li HQ, Pan ZY, Yang Z, et al. Overexpression of MicroRNA-122 resists oxidative stress-induced human umbilical vascular endothelial cell injury by inhibition of p53. Biomed Res Int. 2020a;2020:9791608.
   PubMed Web of Science ®Google Scholar
• Yang S, Zheng Y, Hou X. Lipoxin A4 restores oxidative stress-induced vascular endothelial cell injury and thrombosis-related factor expression by its receptor-mediated activation of Nrf2-HO-1 axis. Cell Signal. 2019;60:146–153.
   PubMed Web of Science ®Google Scholar
• Chen L, Wang J, Wang B, et al. MiR-126 inhibits vascular endothelial cell apoptosis through targeting PI3K/Akt signaling. Ann Hematol. 2016;95(3):365–374.
   PubMed Web of Science ®Google Scholar
• Padilla J, Carpenter AJ, Das NA, et al. TRAF3IP2 mediates high glucose-induced endothelin-1 production as well as endothelin-1-induced inflammation in endothelial cells. Am J Physiol Heart Circ Physiol. 2018;314(1):H52–H64.
   PubMed Web of Science ®Google Scholar
• Xu Z, Zuo ZQ, Gaowa B, et al. The antithrombotic effects of low molecular weight fragment from enzymatically modified of laminaria japonica polysaccharide. Med Sci Monit. 2020;26:e920221.
   PubMed Web of Science ®Google Scholar
• Yamada K, Niki H, Nagai H, et al. Serotonin potentiates high-glucose-induced endothelial injury: the role of serotonin and 5-HT(2A) receptors in promoting thrombosis in diabetes. J Pharmacol Sci. 2012;119(3):243–250.
   PubMed Web of Science ®Google Scholar
• Sestier B. [Hematopoietic stem cell exhaustion and advanced glycation end-products in the unexplained anemia of the elderly]. Rev Esp Geriatr Gerontol. 2015;50(5):223–231.
   PubMedGoogle Scholar
• Yamamoto M, Sugimoto T. Advanced glycation end products, diabetes, and bone strength. Curr Osteoporos Rep. 2016;14(6):320–326.
   PubMed Web of Science ®Google Scholar
• Prasad K, Mishra M. Do advanced glycation end products and its receptor play a role in pathophysiology of hypertension? Int J Angiol. 2017;26(1):1–11.
   PubMed Web of Science ®Google Scholar
• McNair E, Qureshi M, Prasad K, et al. Atherosclerosis and the Hypercholesterolemic AGE-RAGE Axis. Int J Angiol. 2016;25(2):110–116.
   PubMed Web of Science ®Google Scholar
• Adamopoulos C, Piperi C, Gargalionis AN, et al. Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2-NF-kappaB and JNK-AP-1 signaling pathways. Cell Mol Life Sci. 2016;73(2016):1685–1698.
   PubMedGoogle Scholar
• Sanajou D, Ghorbani Haghjo A, Argani H, et al. AGE-RAGE axis blockade in diabetic nephropathy: current status and future directions. Eur J Pharmacol. 2018;833:158–164.
   PubMed Web of Science ®Google Scholar
• Tang Y, Wang J, Cai W, et al. RAGE/NF-kappaB pathway mediates hypoxia-induced insulin resistance in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2020;521(1):77–83.
   PubMed Web of Science ®Google Scholar
• Tobon-Velasco JC, Cuevas E, Torres-Ramos MA. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets. 2014;13(9):1615–1626.
   PubMed Web of Science ®Google Scholar
• Chen D, Shan YX, Dai YT. [Advanced glycation end products and their receptors elevate the activity of endothelin-1 in rat cavernosum]. Zhonghua Nan Ke Xue. 2008;14(2):110–115.
   PubMedGoogle Scholar
• Wang Z, Zhang J, Chen L, et al. Glycine suppresses AGE/RAGE signaling pathway and subsequent oxidative stress by restoring Glo1 function in the aorta of diabetic rats and in HUVECs. Oxid Med Cell Longev. 2019;2019:4628962.
   PubMed Web of Science ®Google Scholar
• Banarjee R, Sharma A, Bai S, et al. Proteomic study of endothelial dysfunction induced by AGEs and its possible role in diabetic cardiovascular complications. J Proteomics. 2018;187:69–79.
   PubMed Web of Science ®Google Scholar
• Tsukushi S, Katsuzaki T, Aoyama I, et al. Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway. Kidney Int. 1999;55(1999):1970–1976.
   PubMedGoogle Scholar
• Chang SL, Huang YL, Lee MC, et al. Association of varicose veins with incident venous thromboembolism and peripheral artery disease. JAMA. 2018;319(8):807–817.
   PubMed Web of Science ®Google Scholar
• Paydar S, Sabetian G, Khalili H, et al. Management of Deep Vein Thrombosis (DVT) prophylaxis in trauma patients. Bull Emerg Trauma. 2016;4(1):1–7.
   PubMedGoogle Scholar
• Branchford BR, Carpenter SL. The role of inflammation in venous thromboembolism. Front Pediatr. 2018;6:142.
   PubMed Web of Science ®Google Scholar
• Gutmann C, Siow R, Gwozdz AM, et al. Reactive oxygen species in venous thrombosis. Int J Mol Sci. 2020;21(6):1918.
   Web of Science ®Google Scholar
• Mazzoccoli G, Fontana A, Grilli M, et al. Idiopathic deep venous thrombosis and arterial endothelial dysfunction in the elderly. Age (Dordr). 2012;34(3):751–760.
   PubMedGoogle Scholar
• Sims GP, Rowe DC, Rietdijk ST, et al. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol. 2010;28(1):367–388.
   PubMed Web of Science ®Google Scholar
• Tang ST, Zhang Q, Tang HQ, et al. Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor kappaB signaling pathways. Endocrine. 2016;53(1):107–116.
   PubMed Web of Science ®Google Scholar
• Ortillon J, Hezard N, Belmokhtar K, et al. Receptor for advanced glycation end products is involved in platelet hyperactivation and arterial thrombosis during chronic kidney disease. Thromb Haemost. 2020;120(9):1300–1312.
   PubMedGoogle Scholar
• Borgel D, Bianchini E, Lasne D, et al. Inflammation in deep vein thrombosis: a therapeutic target? Hematology. 2019;24(1):742–750.
   PubMed Web of Science ®Google Scholar
• Yao X, Chen W, Liu J, et al. Deep vein thrombosis is modulated by inflammation regulated via sirtuin 1/nf-kappab signalling pathway in a rat model. Thromb Haemost. 2019;119(3):421–430.
   PubMed Web of Science ®Google Scholar
• Ndrepepa G. Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease. Clin Chim Acta. 2019;493:36–51.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zennadi R. Oxidative stress and thrombosis during aging: the roles of oxidative stress in RBCs in venous thrombosis. Int J Mol Sci. 2020;21(12):4259.
   Google Scholar
• Costa D, Benincasa G, Lucchese R, et al. Effect of nitric oxide reduction on arterial thrombosis. Scand Cardiovasc J. 2019;53(1):1–8.
   PubMed Web of Science ®Google Scholar
• Cyr AR, Huckaby LV, Shiva SS, et al. Nitric oxide and endothelial dysfunction. Crit Care Clin. 2020;36(2):307–321.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Rghigh A. Polymorphism in endothelin-1 gene: an overview. Curr Clin Pharmacol. 2016;11(3):191–210.
   PubMed Web of Science ®Google Scholar
• Halim A, Kanayama N, El Maradny E, et al. Endothelin-1 increased immunoreactive von Willebrand factor in endothelial cells and induced micro thrombosis in rats. Thromb Res. 1994;76(1):71–78.
   PubMed Web of Science ®Google Scholar
• Kida T, Flammer J, Oku H, et al. Vasoactivity of retinal veins: a potential involvement of endothelin-1 (ET-1) in the pathogenesis of retinal vein occlusion (RVO). Exp Eye Res. 2018;176:207–209.
   PubMed Web of Science ®Google Scholar
• Christakou C, Economou F, Livadas S, et al. Strong and positive association of endothelin-1 with AGEs in PCOS: a causal relationship or a bystander? Hormones (Athens). 2011;10(4):292–297.
   PubMedGoogle Scholar
• Stark K, Philippi V, Stockhausen S, et al. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood. 2016;128(20):2435–2449.
   PubMed Web of Science ®Google Scholar
• Nemoto S, Taguchi K, Matsumoto T, et al. Aminoguanidine normalizes ET-1-induced aortic contraction in type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats by suppressing Jab1-mediated increase in ET(A)-receptor expression. Peptides. 2012;33(1):109–119.
   PubMed Web of Science ®Google Scholar